Blueprint enters into $1.25bn financing collaboration with Sixth Street and Royalty Pharma
The financing from two life science-focused investors is expected to provide capital to expand Blueprint’s pipeline towards commercialisation…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Jul 22
The financing from two life science-focused investors is expected to provide capital to expand Blueprint’s pipeline towards commercialisation…
30 Jun 22
Under the terms of the deal, the companies will supply 105 million doses of their Omicron-adapted Covid-19 vaccines,…
28 Jun 22
The partnership leverages the cancer-fighting potential of iADCs as a novel modality, enabled by Sutro’s ability to engineer…
21 Jun 22
Pfizer and Valneva have updated the terms of their existing collaboration and license agreement for the development of…
17 Jun 22
Exelixis is enabled to expand its biotherapeutics pipeline by selecting antibody candidates against targets identified using BioInvent’s immuno-oncology…
16 Jun 22
Under the collaboration, the Abu Dhabi health regulator and Sanofi will develop data generation and population research projects…
15 Jun 22
With the collaboration with Agilent, Merck will extend its real-time monitoring and automated process control of critical process…
03 Jun 22
Sanofi will receive an upfront payment of $900m, 11% royalty on global sales of Libtayo, and is eligible…
02 Jun 22
The collaboration will identify high-affinity novel antibodies against two different glycoprotein targets, where GO Therapeutics will lead the…
02 Jun 22
Pfizer said that the decision to exit from Haleon is based on its strategy to become a more…